Focal Pulsed Field Ablation and Ultrahigh-density Mapping - Versatile Tools for All Atrial Arrhythmias? Initial Procedural Experiences
Overview
Affiliations
Background: Focal pulsed field ablation (FPFA) is a novel and promising method of cardiac ablation. The aim of this study was to report the feasibility, short-term safety, and procedural findings for a broad spectrum of ablated atrial arrhythmias.
Methods: Patients (n = 51) scheduled for ablation of atrial arrhythmias were prospectively included and underwent FPFA using the Galvanize CENTAURI generator with energy delivery through commercially available ablation catheters with ultrahigh-density (UHDx) 3D electroanatomic voltage/local activation time map evaluations. Workflow, procedural data, and peri-procedural technical errors and complications are described.
Results: Planned ablation strategy was achieved with FPFA-only in 48/51 (94%) of the cases. Ablation strategy was first-time pulmonary vein isolation (PVI) in 17/51 (36%), repeat ablation in 18/51 (38%), PVI + in 13/51 (28%), and cavotricuspid isthmus block (CTI)-only in 3/51 (6%). The mean procedure time was 104 ± 31 min (first-time PVI), 114 ± 26 min (repeat procedure), 152 ± 36 min (PVI +), and 62 ± 17 min (CTI). Mean UHDx mapping time to assess lesion formation and block after ablation was 7 ± 4 min with 5485 ± 4809 points. First pass acute (linear) isolation with bidirectional block for anatomical lesion sets was 120/124 (97%) for all PVs, 17/17 (100%) for (any) isthmus, and 14/17 (82%) for left atrium posterior wall (LAPW). We observed several time-consuming integration errors with the used ablation system (mean 3.4 ± 3.7 errors/procedure), one transient inferior ST elevation when ablating CTI resolved by intravenous nitroglycerine and one transient AV block requiring temporary pacing for > 24 h.
Conclusions: FPFA was a highly versatile method to treat atrial arrhythmias with high first-pass efficiency. UHDx revealed acute homogenous low-voltage lesions in ablated areas. More data is needed to establish lesion durability and limitations of FPFA.
Focal point-by-point biphasic monopolar pulsed field ablation for posterior wall isolation.
Farnir F, Chaldoupi S, Farnir F, Schotten U, Vernooy K, Luermans J Europace. 2024; 26(4).
PMID: 38517287 PMC: 11017520. DOI: 10.1093/europace/euae077.
Focal Pulsed Field Ablation for Atrial Arrhythmias: Efficacy and Safety under Deep Sedation.
Weyand S, Adam V, Biehler P, Hagele P, Hanger S, Heinzmann D J Clin Med. 2024; 13(2).
PMID: 38276082 PMC: 10817052. DOI: 10.3390/jcm13020576.
Farnir F, Luermans J, Manusama R, Uijl D, Chaldoupi S, Linz D HeartRhythm Case Rep. 2024; 10(1):21-25.
PMID: 38264121 PMC: 10801091. DOI: 10.1016/j.hrcr.2023.10.012.
Ruwald M, Haugdal M, Worck R, Johannessen A, Hansen M, Sorensen S J Interv Card Electrophysiol. 2023; 67(2):379-387.
PMID: 37776356 PMC: 10902076. DOI: 10.1007/s10840-023-01655-0.
Worck R, Haugdal M, Johannessen A, Hansen M, Ruwald M, Hansen J Heart Rhythm O2. 2023; 4(7):463-465.
PMID: 37520020 PMC: 10373145. DOI: 10.1016/j.hroo.2023.06.006.